Product Code: Sample_Proteomics Market - Global Outlook & Forecast 2022-2027_Arizton.pdf
The Global Proteomics market is expected to grow at a CAGR of 12.41% during 2022-2027
The following factors will drive the global proteomics market growth during the forecast period:
- Increasing Number of Research and Development Activities in Proteomics
- Rising Prevalence of Cancer and Various Genetic Disorders
- Growing Focus on Development of Precision Medicine
Proteomics is the extensive study of proteins. It is a rapidly growing field in disease diagnosis. Proteomics identifies disease-associated proteins and studies their function, structure, and expression. Proteomics researchers primarily rely on sophisticated technology to deliver actionable insights to advance the field because of the number of complexities in proteomics. Proteomics is a key tool in medical research because it makes it possible to study large-scale proteins from various biological samples to discover new protein biomarkers for different disease conditions.
Proteomics allows for discovering new protein biomarkers for diagnostic applications and the investigation of novel molecular targets for medication development and discovery. Protein expression profiling, targeted protein quantification, protein-protein interaction analysis, and post-translational modifications are all possible using proteomics. Proteomics has demonstrated its utility in biomarker identification, medication development, and precision medicine.
IMPACT OF COVID-19 ON PROTEOMICS MARKET
The impact of COVID-19 is also seen in the proteomics market's growth. There has been increased research on diagnostics, biomarker discovery, and drug discovery and development against COVID-19. It has accelerated the involvement of proteomics. Several large and small companies have constantly been coming up with immunoassay kits to detect COVID-19 rapidly. Along with companies, many public/private research organizations and research institutes also increased the research on the coronavirus involving the proteomics approach extensively.
Proteomics plays a considerable role in drug development, and therefore, many drug manufacturers have started their proteomics divisions that fuel the growth of the global proteomics market.
Existing technologies have several drawbacks, including a lack of specificity, especially in high-multiplex assays, a lack of sensitivity, and a lack of precision; a limited dynamic range (the ability to measure a wide range of concentrations reliably and simultaneously); a high sample consumption requirement; a lack of scalability; a low throughput; data complexity; and a high cost. This scenario is changing over time and will enhance the scope of proteomics.
Proteomics technologies in the market include spectrometry, microarray, chromatography, and reagents used for proteomic analysis. The majority of proteomic analysis primarily relies on an expensive and complex analysis of proteome complexity at the level of amino acid variants, which have the potential to generate important biological insights.
NANOPROTEOMICS: LUCRATIVE OPPORTUNITY IN THE PROTEOMICS MARKET
Nanoproteomics offers real-time multiplexed analysis, rapid and miniatured assay, low sample consumption, and high sensitivity, thereby finding many applications for proteomic investigations.
The growing prominence of nanoproteomics offers significant growth opportunities for players in the market. Nanoproteomics is still in its early stage of enabling broad biomedical applications. In the upcoming years, continuous technological advancement in this field is anticipated. The growing prominence of nanoproteomics offers significant growth opportunities for players in this market.
BGI, a China-based company, has extensive experience in nanoproteomics. The company offers a nanoproteomics service, serving in more than 66 countries. Seer company's photograph product suite, an integrated solution, consists of the company's proprietary engineered nanoparticles, consumables, automation instrument, and software that allows proteomics studies. It reduces the complexity of traditional proteomics. It has commercialized its services using the proteograph product suite with North America, Europe, and the Asia Pacific providers.
CONSUMABLES & REAGENT: HIGHEST REVENUE CONTRIBUTOR
The consumables and reagents segment has the largest market share accounting for 77.08% in 2021. For several decades, many companies have included both small and large companies, relentlessly working to bring more reagents and consumables used in all the areas of proteomics application in the initial step, which is during the sample preparation. Many vital companies offer a wide range of consumables and reagents, such as Agilent Technologies, Bio-Rad Laboratories, and Thermo Fisher Scientific. An increase in the reagent's portfolio is evitable with the increasing proteomics research worldwide. These factors make the consumables and reagents segment the highest revenue maker, with $19.37 billion in 2021.
THE INSTRUMENTS AND SOFTWARE MARKET IS TO GROW AT A CAGR OF 13% FROM 2022 TO 2027.
Most key companies offer a wide range of instruments for microarray, spectrometry, chromatography, electrophoresis, surface plasma resonance, and x-ray crystallography. With the increasing research on biomarker discovery and drug discovery and development, several pharmaceutical companies and academic & research institutes are expected to increase the implementation of instruments and software in their laboratories. Hence, the instruments & software segment is expected to increase in the forecast period with a CAGR of 13%.
END-USER INSIGHTS
Among all the end-users, the pharmaceutical and biotechnology companies segment is growing due to the development and demand of the increasing diagnostic for drug development. The surge in the use of proteomic technology is also due to the rising adoption of precision medicine driven by biomarkers identification and discovery in response to the increasing prevalence of chronic diseases such as cancer mainly.
Several academic and research institutes are also the second major revenue generator in the proteomics market, increasing research on developing drugs and vaccines. Hospitals are also using proteomics technologies for disease diagnosis purposes. They either have their in-house pathology laboratory or collaborate with a diagnostic laboratory, and they get the diagnosis done by sending the samples. In collaboration or partnership with proteomics companies, several hospitals are enabling the companies to develop related proteomic technologies.
Forensic laboratories are also contributing and accounting for a good market share in growing the proteomics markets by receiving massive funding and investments to conduct research in forensic science for protein identification and biomarker discovery.
Market Segmentation by Product
- Consumables & Reagents
- Instruments & Software
- Services
Market Segmentation by Application
- DDD & TR
- Clinical
- Applications
- Forensic & Applied Proteomics
Market Segmentation by End-User
- Pharma & Biotech
- Academic & Research Institutes
- Hospitals
- Diagnostic & Forensic
WIDE ACCEPTANCE AMONG ACADEMIC AND RESEARCH INSTITUTES
While Pharmaceutical and Biotechnology, companies are the highest revenue generator segment, with $11.76 billion in 2021. Academic & research institutes are the most significant users of proteomics technologies for various ongoing research activities in multiple dimensions: discovery, new technology innovations, better product advancements, academic training, etc. The Academic and Research institutes segment is expected to grow at the highest CAGR of 12.91%.
GEOGRAPHY INSIGHTS
Increasing adoption of personalized medicine, increasing R&D expenditures for drug discovery, biomarker discovery, and biomarker-driven development of precision medicine are the major factors that drive the growth of the proteomics market worldwide.
Increasing awareness among the people regarding applications of proteomics in drug discovery and development, biomarker discovery, and clinical diagnostics for disease diagnosis and treatment is also propelling the market's growth. Some private and public research organizations focus on developing proteomics based on spectrometry.
In North America, Europe, and APAC region, increased funding by the government for the R&D activities boosts growth opportunities for the key players in the market to develop advanced proteomics diagnostics and instruments in the forecast period. However, in these regions, a lack of skilled professionals is limiting the growth of the proteomics market. In North America and APAC region, the introduction of nanotechnology in proteomics is trending and has shown vast opportunities for acceptance. For instance, in China, BGI Genomics is offering nano proteomics services.
Middle East, Africa, and Latin America are showing a growing focus on the adoption of precision medicine. The governments have taken several initiatives to accelerate the growth of the proteomics market in Latin America, the Middle East, and Africa. Also, the rising popularity of personalized medicine increased research on biomarkers and drug discovery, driving the proteomics market in Latin America, the Middle East, and Africa. However, stringent regulatory norms and the high cost of proteomics instruments, lack of funds and investments, lack of awareness about proteomics, and lack of skilled professionals are restraining these regions from adopting advanced proteomics approaches.
Regions
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- Japan
- China
- South Korea
- Australia
- India
- Latin America
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
VENDOR ANALYSIS
Vendors are divided into both manufacturers and service providers. The proteomics market is highly dynamic and competitive, with global, regional, and local players offering a wide range of proteomics solutions. Agilent Technologies, Bio-Rad Laboratories, Thermo-Fisher Scientific, Danaher, and PerkinElmer are the significant players in providing products in proteomics, whereas BGI Group is a substantial player in offering proteomics services.
- Expansion activities (regional business and facility expansions) are helping players strengthen the global distribution networks and thus allowing the players to explore untapped opportunities.
- Increasing product launches
- Large scale investments in the single-use bioprocessing probes and sensors market through varied conglomerates and investments firms
- Forging collaborations and partnerships with well-established manufacturers, academic & research institutes, hospitals, and diagnostic & forensic laboratories is cementing the players' footprints.
- Strategic acquisitions continue to be an essential competitive strategy for key players to expand their product offerings, access new technology, or increase market share.
- In low and middle-income countries, the service providers are mainly in demand as these countries do lack proper healthcare infrastructure.
- Service providers are focusing on increasing the collaborations with hospitals and several pharmaceutical companies to grow in the market.
The need for companies that provide proteomics services has drawn the attention of many researchers from laboratories that are not equipped with advanced technologies for proteomic research. This could be due to a lack of skilled professionals or in-house infrastructure, as increased demand for proteomics research. Many companies have emerged by providing protein identification, quantification, sequencing, purification, and custom assay services.
Key Vendors
- Agilent Technologies
- Bio-Rad Laboratories
- Danaher
- Thermo Fisher Scientific
- PerkinElmer
- BGI Genomics
Other Prominent Vendors by Product
- Bruker
- DiaSorin
- HORIBA
- Illumina
- INOVIQ
- LI-COR
- Nautilus Biotechnology
- Proteome Factory
- QIAGEN
- Rhythm Biosciences
- Shimadzu Scientific Instruments
- Seer
- Waters
Other Prominent Vendors by Service
- Applied Biomics
- Creative Proteomics
- Poochon Scientific
- SomaLogic
- Vproteomics
Other Prominent Vendors by Product & Services
- Abcam
- AnteoTech
- AYOXXA Biosystems
- Biognosys
- Geneilabs
- Grace Bio-Labs
- ITSI-Biosciences
- MSAID
- Olink
- Promega
- Proteomics International
- Quanterix
KEY QUESTIONS ANSWERED
- 1. HOW BIG IS THE GLOBAL PROTEOMICS MARKET?
- 2. WHAT IS THE GROWTH RATE OF THE GLOBAL PROTEOMICS MARKET?
- 3. WHO ARE THE KEY PLAYERS IN THE GLOBAL PROTEOMICS MARKET?
- 4. WHAT ARE THE GROWTH FACTORS IN THE GLOBAL PROTEOMICS MARKET?
- 5. WHAT ARE THE LATEST TRENDS IN THE GLOBAL PROTEOMICS MARKET?
TABLE OF CONTENTS
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY PRODUCT
- 4.3.2 MARKET SEGMENTATION BY APPLICATION
- 4.3.3 MARKET SEGMENTATION BY END USER
- 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
- 7.1 OVERVIEW
- 7.1.1 LOW-THROUGHPUT METHODS
- 7.1.2 HIGH-THROUGHPUT METHODS
8 MARKET OPPORTUNITIES & TRENDS
- 8.1 INCREASING PROMINENCE OF NANOPROTEOMICS
- 8.2 DEVELOPMENTS IN MASS SPECTROMETRY-BASED PROTEOMICS
- 8.3 PROMINENT ROLE OF PROTEOMICS IN DIABETES MANAGEMENT
9 MARKET GROWTH ENABLERS
- 9.1 RISING NUMBER OF R&D PROJECTS IN PROTEOMICS
- 9.2 INCREASING PREVALENCE OF CANCER AND VARIOUS GENETIC DISORDERS
- 9.3 GROWING FOCUS ON DEVELOPMENT OF PRECISION MEDICINE
10 MARKET RESTRAINTS
- 10.1 LIMITATIONS ASSOCIATED WITH ACCESSING PROTEOME
- 10.2 DEARTH OF SKILLED PROFESSIONALS
- 10.3 STRICT REGULATORY NORMS & HIGH COST OF INSTRUMENTS
11 MARKET LANDSCAPE
- 11.1 MARKET OVERVIEW
- 11.2 MARKET SIZE & FORECAST
- 11.2.1 INSIGHTS BY PRODUCT
- 11.2.2 INSIGHTS BY APPLICATION
- 11.2.3 INSIGHTS BY END USERS
- 11.2.4 INSIGHTS BY GEOGRAPHY
- 11.3 FIVE FORCES ANALYSIS
- 11.3.1 THREAT OF NEW ENTRANTS
- 11.3.2 BARGAINING POWER OF SUPPLIERS
- 11.3.3 BARGAINING POWER OF BUYERS
- 11.3.4 THREAT OF SUBSTITUTES
- 11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
- 12.1 MARKET SNAPSHOT & GROWTH ENGINE
- 12.2 MARKET OVERVIEW
- 12.3 CONSUMABLES & REAGENTS
- 12.3.1 MARKET OVERVIEW
- 12.3.2 MARKET SIZE & FORECAST
- 12.3.3 MARKET BY GEOGRAPHY
- 12.4 INSTRUMENTS & SOFTWARE
- 12.4.1 MARKET OVERVIEW
- 12.4.2 MARKET SIZE & FORECAST
- 12.4.3 MARKET BY GEOGRAPHY
- 12.5 SERVICES
- 12.5.1 MARKET OVERVIEW
- 12.5.2 MARKET SIZE & FORECAST
- 12.5.3 MARKET BY GEOGRAPHY
13 APPLICATION
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 DRUG DISCOVERY & DEVELOPMENT AND TRANSLATIONAL RESEARCH
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 CLINICAL APPLICATIONS
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 13.5 FORENSICS & APPLIED PROTEOMICS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
14 END USER
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 ACADEMIC & RESEARCH INSTITUTES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
- 14.5 HOSPITALS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
- 14.6 DIAGNOSTIC & FORENSIC LABORATORIES
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY
15 GEOGRAPHY
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 GEOGRAPHIC OVERVIEW
16 NORTH AMERICA
- 16.1 MARKET OVERVIEW
- 16.2 MARKET SIZE & FORECAST
- 16.3 NORTH AMERICA: PRODUCT SEGMENTATION
- 16.4 NORTH AMERICA: APPLICATION SEGMENTATION
- 16.5 NORTH AMERICA: END-USER SEGMENTATION
- 16.6 KEY COUNTRIES
- 16.6.1 US: MARKET SIZE & FORECAST
- 16.6.2 CANADA: MARKET SIZE & FORECAST
17 EUROPE
- 17.1 MARKET OVERVIEW
- 17.2 MARKET SIZE & FORECAST
- 17.3 EUROPE: PRODUCT SEGMENTATION
- 17.4 EUROPE: APPLICATION SEGMENTATION
- 17.5 EUROPE: END-USER SEGMENTATION
- 17.6 KEY COUNTRIES
- 17.6.1 GERMANY: MARKET SIZE & FORECAST
- 17.6.2 FRANCE: MARKET SIZE & FORECAST
- 17.6.3 UK: MARKET SIZE & FORECAST
- 17.6.4 ITALY: MARKET SIZE & FORECAST
- 17.6.5 SPAIN: MARKET SIZE & FORECAST
18 APAC
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 APAC: PRODUCT SEGMENTATION
- 18.4 APAC: APPLICATION SEGMENTATION
- 18.5 APAC: END-USER SEGMENTATION
- 18.6 KEY COUNTRIES
- 18.6.1 JAPAN: MARKET SIZE & FORECAST
- 18.6.2 CHINA: MARKET SIZE & FORECAST
- 18.6.3 SOUTH KOREA: MARKET SIZE & FORECAST
- 18.6.4 AUSTRALIA: MARKET SIZE & FORECAST
- 18.6.5 INDIA: MARKET SIZE & FORECAST
19 LATIN AMERICA
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 LATIN AMERICA: PRODUCT SEGMENTATION
- 19.4 LATIN AMERICA: APPLICATION SEGMENTATION
- 19.5 LATIN AMERICA: END-USER SEGMENTATION
- 19.6 KEY COUNTRIES
- 19.6.1 BRAZIL: MARKET SIZE & FORECAST
- 19.6.2 MEXICO: MARKET SIZE & FORECAST
- 19.6.3 ARGENTINA: MARKET SIZE & FORECAST
20 MIDDLE EAST & AFRICA
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
- 20.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
- 20.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
- 20.6 KEY COUNTRIES
- 20.6.1 TURKEY: MARKET SIZE & FORECAST
- 20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
- 20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
- 21.1 COMPETITION OVERVIEW
- 21.2 MARKET SHARE ANALYSIS
- 21.2.1 AGILENT TECHNOLOGIES
- 21.2.2 BIO-RAD LABORATORIES
- 21.2.3 THERMO FISHER SCIENTIFIC
- 21.2.4 DANAHER
- 21.2.5 PERKINELMER
- 21.2.6 BGI GROUP
22 KEY COMPANY PROFILES
- 22.1 AGILENT TECHNOLOGIES
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 PRODUCT OFFERINGS
- 22.1.3 KEY STRATEGIES
- 22.1.4 KEY STRENGTHS
- 22.1.5 KEY OPPORTUNITIES
- 22.2 BIO-RAD LABORATORIES
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 PRODUCT OFFERINGS
- 22.2.3 KEY STRATEGIES
- 22.2.4 KEY STRENGTHS
- 22.2.5 KEY OPPORTUNITIES
- 22.3 DANAHER
- 22.3.1 BUSINESS OVERVIEW
- 22.3.2 PRODUCT OFFERINGS
- 22.3.3 KEY STRATEGIES
- 22.3.4 KEY STRENGTHS
- 22.3.5 KEY OPPORTUNITIES
- 22.4 THERMO FISHER SCIENTIFIC
- 22.4.1 BUSINESS OVERVIEW
- 22.4.2 PRODUCT OFFERINGS
- 22.4.3 KEY STRATEGIES
- 22.4.4 KEY STRENGTHS
- 22.4.5 KEY OPPORTUNITIES
- 22.5 PERKINELMER
- 22.5.1 BUSINESS OVERVIEW
- 22.5.2 PRODUCT OFFERINGS
- 22.5.3 KEY STRATEGIES
- 22.5.4 KEY STRENGTHS
- 22.5.5 KEY OPPORTUNITIES
- 22.6 BGI GROUP
- 22.6.1 BUSINESS OVERVIEW
- 22.6.2 PRODUCT OFFERINGS
- 22.6.3 KEY STRATEGIES
- 22.6.4 KEY STRENGTHS
- 22.6.5 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS - BY PRODUCT
- 23.1 BRUKER
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.2 DIASORIN
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.3 HORIBA
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.4 ILLUMINA
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.5 INOVIQ
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
- 23.6 LI-COR BIOSCIENCES
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 PRODUCT OFFERINGS
- 23.7 NAUTILUS BIOTECHNOLOGY
- 23.7.1 BUSINESS OVERVIEW
- 23.7.2 PRODUCT OFFERINGS
- 23.8 PROTEOME FACTORY
- 23.8.1 BUSINESS OVERVIEW
- 23.8.2 PRODUCT OFFERINGS
- 23.9 QIAGEN
- 23.9.1 BUSINESS OVERVIEW
- 23.9.2 PRODUCT OFFERINGS
- 23.10 RHYTHM BIOSCIENCES
- 23.10.1 BUSINESS OVERVIEW
- 23.10.2 PRODUCT OFFERINGS
- 23.11 SHIMADZU SCIENTIFIC INSTRUMENTS
- 23.11.1 BUSINESS OVERVIEW
- 23.11.2 PRODUCT OFFERINGS
- 23.12 SEER
- 23.12.1 BUSINESS OVERVIEW
- 23.12.2 PRODUCT OFFERINGS
- 23.13 WATERS
- 23.13.1 BUSINESS OVERVIEW
- 23.13.2 PRODUCT OFFERINGS
24 SERVICE PROVIDERS
- 24.1 APPLIED BIOMICS
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
- 24.2 CREATIVE PROTEOMICS
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
- 24.3 POOCHON SCIENTIFIC
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
- 24.4 SOMALOGIC
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
- 24.5 VPROTEOMICS
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
25 PRODUCT & SERVICE PROVIDERS
- 25.1 ABCAM
- 25.1.1 BUSINESS OVERVIEW
- 25.1.2 PRODUCT & SERVICE OFFERINGS
- 25.2 ANTEOTECH
- 25.2.1 BUSINESS OVERVIEW
- 25.2.2 PRODUCT & SERVICE OFFERINGS
- 25.3 AYOXXA BIOSYSTEMS
- 25.3.1 BUSINESS OVERVIEW
- 25.3.2 PRODUCT & SERVICE OFFERINGS
- 25.4 BIOGNOSYS
- 25.4.1 BUSINESS OVERVIEW
- 25.4.2 PRODUCT & SERVICE OFFERINGS
- 25.5 GENEI LABORATORIES
- 25.5.1 BUSINESS OVERVIEW
- 25.5.2 PRODUCT OFFERINGS
- 25.6 GRACE BIO-LABS
- 25.6.1 BUSINESS OVERVIEW
- 25.6.2 PRODUCT & SERVICE OFFERINGS
- 25.7 ITSI-BIOSCIENCES
- 25.7.1 BUSINESS OVERVIEW
- 25.7.2 PRODUCT & SERVICE OFFERINGS
- 25.8 MSAID
- 25.8.1 BUSINESS OVERVIEW
- 25.8.2 PRODUCT & SERVICE OFFERINGS
- 25.9 OLINK
- 25.9.1 BUSINESS OVERVIEW
- 25.9.2 PRODUCT & SERVICE OFFERINGS
- 25.10 PROMEGA
- 25.10.1 BUSINESS OVERVIEW
- 25.10.2 PRODUCT & SERVICE OFFERINGS
- 25.11 PROTEOMICS INTERNATIONAL
- 25.11.1 BUSINESS OVERVIEW
- 25.11.2 PRODUCT & SERVICE OFFERINGS
- 25.12 QUANTERIX
- 25.12.1 BUSINESS OVERVIEW
- 25.12.2 PRODUCT & SERVICE OFFERINGS
26 REPORT SUMMARY
- 26.1 KEY TAKEAWAYS
- 26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
- 27.1 MARKET BY GEOGRAPHY
- 27.2 MARKET BY PRODUCT
- 27.3 MARKET BY APPLICATION
- 27.4 MARKET BY END USER
- 27.5 NORTH AMERICA BY PRODUCT
- 27.6 NORTH AMERICA BY APPLICATION
- 27.7 NORTH AMERICA BY END USER
- 27.8 EUROPE BY PRODUCT
- 27.9 EUROPE BY APPLICATION
- 27.10 EUROPE BY END USER
- 27.11 APAC BY PRODUCT
- 27.12 APAC BY APPLICATION
- 27.13 APAC BY END USER
- 27.14 LATIN AMERICA BY PRODUCT
- 27.15 LATIN AMERICA BY APPLICATION
- 27.16 LATIN AMERICA BY END USER
- 27.17 MIDDLE EAST & AFRICA BY PRODUCT
- 27.18 MIDDLE EAST & AFRICA BY APPLICATION
- 27.19 MIDDLE EAST & AFRICA BY END USER
28 APPENDIX